Diabetes Drugs Flashcards

1
Q

What is the ultimate result of T1 and T2 DM?

A

Hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Polyuria, polydipsia, glucosuria, unexplained weight loss despite polyphagia, fatigue & blurred vision and in some cases ketoacidosis

A

T1DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Obesity, fatigue, polyuria and polydipsia can be present, although patients are often asymptomatic. IFG and IGT can be detected and precede the onset of diabetes.

A

T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the treatment goals for diabetes?

A

Try to achieve and maintain glycemic control as close to the normal range as possible to prevent the chronic complications of sustained hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the main SE of intensive insulin therapy for diabetes?

A

Increased risk of hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the only treatment for T1DM?

A

Insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What transporter does insulin upregulate in liver, muscle and adipose?

A

GLUT4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 4 classes of insulin?

A
  • Rapid acting
  • Regular
  • Intermediate acting
  • Long acting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What insulin type are detmir and glargine?

A

Long acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can happen if the same sites are continuously used for insulin?

A

Lipodystrophy - inappropriate lipid storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Insulin SE

A

Hypoglycemia

  • Tremor
  • Palpitations
  • Intense Hunger
  • Headaches
  • Altered Mental Status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is non-medical treatment for T2DM?

A

Change in diet and exercise - this can increase insulin sensitivity and decrease BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What type of surgery can benefit T2DM patients?

A

Bariatric Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the DOC for treating all T2DM patients?

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is metformin associated with weight gain?

A

NO - actually can cause weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the main advantage of metformin?

A

No hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Metformin Effects

A
  • Lowers fasting plasma glucose
  • Decreased hepatic gluconeogenesis
  • Increased insulin sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Metformin MOA

A

Inhibits the first unit of the electron transport chain which leads to decreased ATP and increased AMP which inhibits adenylate cyclase blocking glucagon’s pathway.

***Overall decreases gluconeogenesis and increases insulin sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Metformin SE

A
  • Inhibits absorption of Vitamin B12

- Lactic acidosis - rare but can be FATAL (high risk patients)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the mechanism of lactic acidosis in use of metformin?

A

Inhibition of gluconeogenesis decreases lactate being used up as a substrate which increases its concentration. When combined with another condition like decreased renal clearance of lactate, it can lead to toxic build-up.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Metformin Contraindications

A
  • Pregnancy and lactation
  • Impaired liver or renal function
  • Elderly
  • Use of contrast agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the thiazolidinediones and what is their effect?

A
  • Pioglitazone
  • Rosiglitazone
    “Insulin sensitizers” that increase the sensitivity of adipose tissue, skeletal muscle and liver to the effects of endogenous insulin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pioglitazone/Rosiglitazone MOA

A

Thiazolidinediones are agonists for the peroxisome proliferator-activated
receptor-transcription factor (PPAR). Activation of the PPAR transcription factor by thiazolidinediones influences the expression of multiple genes involved in promoting 1) increased insulin sensitivity and 2) decreased plasma glucose levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pioglitazone/Rosiglitazone Indications

A
  • Mono or combo therapy for T2DM

* ** Takes time to see efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Pioglitazone/Rosiglitazone SE

A
  • Weight gain
  • Fluid retention
  • Increased bone fracture risk in women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Pioglitazone/Rosiglitazone Contraindications

A
  • Liver disease
  • Heart failure
  • Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the insulin secretagogues?

A
  • Sulfonylureas

- Meglitinides

28
Q

What are the sulfonylureas?

A
  • Glimepiride
  • Glyburide
  • Glipizide
29
Q

What are the meglitinides?

A
  • Repaglinide

- Nateglinide

30
Q

Sulfonylurea MOA

A

Bind Sur1 and block the channel leading to increased intracellular K+ leading to depolarization and activation of Ca2+ channels to release pre-formed insulin

31
Q

Sulfonylurea Indication

A

Reduce fasting plasma glucose - long duration of action

32
Q

What is the action of sulfonylureas dependent upon?

A

Functional beta cells

33
Q

Sulfonylurea SE

A
  • Hypoglycemia

- Weight gain

34
Q

Sulfonylurea Contraindications

A
  • Elderly (renal impairment)
  • Renal or liver disease
  • T1DM
  • Pregnancy
  • Sulfa allergy
35
Q

Sulfonylurea DDIs

A

Highly protein bound so can interact with:

  • Aspirin
  • Warfarin
36
Q

Meglitinide MOA

A

Bind different region of Sur1 leading to secretion of pre-formed insulin but has a RAPID and SHORTER duration that sulfonylureas

37
Q

What is melitinide dependent on?

A

Glucose - less risk of hypoglycemia

38
Q

Nateglinide affects primarily only _________

A

Postprandial glucose

39
Q

Repaglinide affects both ____________ and _____________.

A

Postprandial and fasting glucose

40
Q

Melitinide SE

A
  • Hypoglycemia

- Weight gain

41
Q

Meglitinide Contraindication

A
  • Liver disease

- Pregnancy

42
Q

What is the incretin effect?

A

Plasma insulin levels to oral glucose are significantly greater than to IV glucose

43
Q

GLP-1

A

Made by L cells of small intestine and mediates the incretin effect

44
Q

What degrades GLP-1?

A

DPP-IV

45
Q

Exenatide/Liraglutide Indications

A
  • Alternative to insulin in T2DM
46
Q

Exenatide/Liraglutide Effects

A
  • Reduce fasting and postpradial glucose

- Promotes weight loss

47
Q

Exenatide/Liraglutide SE

A

Minor GI effects

48
Q

Exenatide/Liraglutide MOA

A

GLP-1 homologs

49
Q

Sitagliptin/Saxagliptin MOA

A

DPP-IV inhibitors - increase half life of GLP-1

50
Q

Sitagliptin/Saxagliptin Indications

A
  • Decrease fasting and prostprandial glucose

- Mono or combo therapy for T2DM

51
Q

Acarbose/Miglitol MOA

A

Inhibit alpha-glucosidase which hydrolyzes dietary carbohydrates and delays the absorption of glucose

52
Q

Acarbose/Miglitol Indications

A
  • Postprandial hyperglycemia control
  • Less potent than sulfonylureas and metformin

NOT 1st line

53
Q

Acarbose/Miglitol SE

A
  • GI effects from unabsorbed carbohydrates

Do NOT cause hypoglycemia

54
Q

Acarbose/Miglitol Contraindications

A

GI diseases

55
Q

Canagliflozin/Dapagliflozin MOA

A

Inhibit SGLT2 in proximal renal tubule which prevents the normal process of glucose reabsorption

56
Q

Canagliflozin/Dapagliflozin Indications

A
  • Mono and combo therapy for T2DM
57
Q

What are the effects of Canagliflozin/Dapagliflozin?

A
  • Weight loss

- Decreased BP

58
Q

Canagliflozin/Dapagliflozin SE

A
  • UTIs
  • Thirst/dehydration
  • Increase LDL cholesterol
59
Q

Canagliflozin/Dapagliflozin Contraindications

A

Renal Impairment

60
Q

Bromocriptine MOA

A

DOPA D2 agonist - exact MOA for diabetes is unknown but thought to normalize morning DOPA levels

61
Q

Colesevalam MOA

A

Increases bile acid synthesis by increasing excretion of bile by binding to bile and preventing reabsorption -which leads to lowering of LDL

62
Q

Colesevalam Indications

A

Add on therapy to 1st line treatments for T2DM

63
Q

What is the most effective medication to lower hyperglycemia?

A

Insulin

64
Q

Pramlintide MOA

A

Amylin homolog - amylin is endogenous hormone that is co-secreted with insulin and contributes to post-prandial glucose control

65
Q

Pramlintide Effects

A
  • Inhibits hepatic gluconeogeneis
  • Slow gastric emptying
  • Inhibits glucagon
  • Increases satiety
66
Q

Pramlintide Indications

A

Adjunct therapy in T1 or T2 patients using insulin but are not at adequate control

67
Q

Pramlintide SE

A
  • Weight loss
  • GI effects
  • Risk for severe hypoglycemia